跳至主要内容
临床试验/2024-519529-40-00
2024-519529-40-00招募中3 期

“USE OF A FIBRIN ADHESIVE TO REDUCE ESOPHAGOYEJUNAL ANASTOMOSIS DEHISCENCE IN TOTAL GASTRECTOMIES FOR CANCER: RANDOMIZED AND MULTICENTER STUDY”

Hospital Germans Trias I Pujol13 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2025年1月15日最近更新:
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
240
试验地点
13
主要终点
Suture dehiscence diagnosed within the first seven days after surgery, using clinical and/or radiological parameters. Csendes classification

研究概览

简要总结

The trial would be conducted with the aim of evaluating the efficacy of fibrin-based adhesive in reducing the incidence of dehiscence in esophagojejunal anastomoses in total gastrectomies for cancer.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Patients of both sexes over 18 years of age.
  • Diagnosis of gastric cancer with AP of gastric adenocarcinoma and possibility of total gastrectomy with curative intent. Tumors with AP characteristics other than gastric adenocarcinoma are excluded (see ‘Exclusion Criteria’)
  • Patients undergoing surgery in trial participants hospital centers
  • understand and accept the trial procedures and sign an informed consent.

排除标准

  • Not meeting the inclusion criteria.
  • Intraoperative diagnosis (during surgery) of non-epithelial neoplasia,metastasis, patients with unresected tumor or undergoing palliative resections.
  • Use of other sealing or anastomosis reinforcing products other than the drug under study (TISSEEL Solutions for tissue adhesive)
  • Subjects who are intolerant or have experienced serious adverse events to products made from fibrin adhesive
  • Pregnant or lactating women
  • Subjects who are unable to understand the nature of the trial and the procedures they are required to follow.
  • Failure to sign the informed consent.

结局指标

主要结局

Suture dehiscence diagnosed within the first seven days after surgery, using clinical and/or radiological parameters. Csendes classification

Suture dehiscence diagnosed within the first seven days after surgery, using clinical and/or radiological parameters. Csendes classification

次要结局

  • Type of anastomosis performed: manual, mechanical (circular or linear)
  • Amylases in drainage on days 1,3,5,7 postoperatively or until the drainage is removed.
  • Leukocytes, procalcitonin, C-reactive protein in blood on days 0,1,3,5,7 postoperatively.
  • Day of CT with oral contrast. CT findings according to Goense score
  • Postoperative complication and type (Clavien Dindo Classification)
  • Need for urgent surgical reintervention
  • In-hospital and 90-day mortality
  • Date of hospital discharge
  • Readmissions at 30 and 90 days

研究者

发起方
Hospital Germans Trias I Pujol
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Yolanda Soler Gonzalez

Scientific

Hospital Germans Trias I Pujol

研究点 (13)

Loading locations...

相似试验